ID   S27A4_HUMAN             Reviewed;         643 AA.
AC   Q6P1M0; A8K2F7; O95186; Q96G53;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   15-MAR-2017, entry version 130.
DE   RecName: Full=Long-chain fatty acid transport protein 4;
DE            Short=FATP-4;
DE            Short=Fatty acid transport protein 4;
DE            EC=6.2.1.-;
DE   AltName: Full=Solute carrier family 27 member 4;
GN   Name=SLC27A4; Synonyms=ACSVL4, FATP4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=9878842; DOI=10.1016/S0167-4781(98)00231-0;
RA   Fitscher B.A., Riedel H.D., Young K.C., Stremmel W.;
RT   "Tissue distribution and cDNA cloning of a human fatty acid transport
RT   protein (hsFATP4).";
RL   Biochim. Biophys. Acta 1443:381-385(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   VARIANT SER-209.
RX   PubMed=14715877; DOI=10.1210/jc.2003-030682;
RA   Gertow K., Bellanda M., Eriksson P., Boquist S., Hamsten A.,
RA   Sunnerhagen M., Fisher R.M.;
RT   "Genetic and structural evaluation of fatty acid transport protein-4
RT   in relation to markers of the insulin resistance syndrome.";
RL   J. Clin. Endocrinol. Metab. 89:392-399(2004).
RN   [8]
RP   VARIANTS IPS THR-92; PRO-247; ARG-300 AND HIS-583.
RX   PubMed=19631310; DOI=10.1016/j.ajhg.2009.06.021;
RA   Klar J., Schweiger M., Zimmerman R., Zechner R., Li H., Torma H.,
RA   Vahlquist A., Bouadjar B., Dahl N., Fischer J.;
RT   "Mutations in the fatty acid transport protein 4 gene cause the
RT   ichthyosis prematurity syndrome.";
RL   Am. J. Hum. Genet. 85:248-253(2009).
RN   [9]
RP   VARIANT IPS CYS-374.
RX   PubMed=20815031; DOI=10.1002/ajmg.a.33648;
RA   Morice-Picard F., Leaute-Labreze C., Decor A., Boralevi F.,
RA   Lacombe D., Taieb A., Fischer J.;
RT   "A novel mutation in the fatty acid transport protein 4 gene in a
RT   patient initially described as affected by self-healing congenital
RT   verruciform hyperkeratosis.";
RL   Am. J. Med. Genet. A 152:2664-2665(2010).
CC   -!- FUNCTION: Involved in translocation of long-chain fatty acids
CC       (LFCA) across the plasma membrane. Appears to be the principal
CC       fatty acid transporter in small intestinal enterocytes. Plays a
CC       role in the formation of the epidermal barrier. Required for fat
CC       absorption in early embryogenesis. Has acyl-CoA ligase activity
CC       for long-chain and very-long-chain fatty acids (VLCFAs).
CC       Indirectly inhibits RPE65 via substrate competition and via
CC       production of VLCFA derivatives like lignoceroyl-CoA. Prevents
CC       light-induced degeneration of rods and cones (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}. Endoplasmic reticulum membrane
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6P1M0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6P1M0-2; Sequence=VSP_055808, VSP_055809;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed at highest levels in brain, testis,
CC       colon and kidney. Expressed at medium levels in heart and liver,
CC       small intestine and stomach. Expressed at low levels in peripheral
CC       leukocytes, bone marrow, skeletal muscle and aorta. Expressed in
CC       adipose tissue. {ECO:0000269|PubMed:9878842}.
CC   -!- DISEASE: Ichthyosis prematurity syndrome (IPS) [MIM:608649]: A
CC       keratinization disorder characterized by complications in the
CC       second trimester of pregnancy resulting from polyhydramnion, with
CC       premature birth of a child with thick caseous desquamating
CC       epidermis, respiratory complications and transient eosinophilia.
CC       After recovery during the first months of life, the symptoms are
CC       relatively benign and the patients suffer from a lifelong non-
CC       scaly ichthyosis with atopic manifestations.
CC       {ECO:0000269|PubMed:19631310, ECO:0000269|PubMed:20815031}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- MISCELLANEOUS: SLC27A4/FATP4-mediated fatty acid uptake is
CC       associated to paramaters related to insulin resistance, which is
CC       associated with disturbed fatty acid metabolism and homeostasis,
CC       such as obesity. SLC27A4/FATP4 expression is positively correlated
CC       with acquired obesity.
CC   -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD11623.1; Type=Frameshift; Positions=362, 387, 612, 619; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF055899; AAD11623.1; ALT_FRAME; mRNA.
DR   EMBL; AK290222; BAF82911.1; -; mRNA.
DR   EMBL; AL359091; CAI13490.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW87779.1; -; Genomic_DNA.
DR   EMBL; BC009959; AAH09959.1; -; mRNA.
DR   EMBL; BC065003; AAH65003.1; -; mRNA.
DR   CCDS; CCDS6899.1; -. [Q6P1M0-1]
DR   RefSeq; NP_005085.2; NM_005094.3. [Q6P1M0-1]
DR   RefSeq; XP_016869711.1; XM_017014222.1. [Q6P1M0-1]
DR   UniGene; Hs.656699; -.
DR   ProteinModelPortal; Q6P1M0; -.
DR   BioGrid; 116192; 15.
DR   IntAct; Q6P1M0; 22.
DR   MINT; MINT-8376036; -.
DR   STRING; 9606.ENSP00000300456; -.
DR   BindingDB; Q6P1M0; -.
DR   ChEMBL; CHEMBL4327; -.
DR   GuidetoPHARMACOLOGY; 1111; -.
DR   SwissLipids; SLP:000000451; -.
DR   TCDB; 4.C.1.1.10; the fatty acid transporter (fat) family.
DR   iPTMnet; Q6P1M0; -.
DR   PhosphoSitePlus; Q6P1M0; -.
DR   SwissPalm; Q6P1M0; -.
DR   BioMuta; SLC27A4; -.
DR   DMDM; 74749065; -.
DR   EPD; Q6P1M0; -.
DR   MaxQB; Q6P1M0; -.
DR   PaxDb; Q6P1M0; -.
DR   PeptideAtlas; Q6P1M0; -.
DR   PRIDE; Q6P1M0; -.
DR   Ensembl; ENST00000300456; ENSP00000300456; ENSG00000167114. [Q6P1M0-1]
DR   Ensembl; ENST00000372870; ENSP00000361961; ENSG00000167114. [Q6P1M0-2]
DR   GeneID; 10999; -.
DR   KEGG; hsa:10999; -.
DR   UCSC; uc004but.4; human. [Q6P1M0-1]
DR   CTD; 10999; -.
DR   DisGeNET; 10999; -.
DR   GeneCards; SLC27A4; -.
DR   HGNC; HGNC:10998; SLC27A4.
DR   HPA; CAB009771; -.
DR   HPA; HPA007293; -.
DR   MalaCards; SLC27A4; -.
DR   MIM; 604194; gene.
DR   MIM; 608649; phenotype.
DR   neXtProt; NX_Q6P1M0; -.
DR   OpenTargets; ENSG00000167114; -.
DR   Orphanet; 88621; Ichthyosis prematurity syndrome.
DR   PharmGKB; PA35872; -.
DR   eggNOG; KOG1179; Eukaryota.
DR   eggNOG; ENOG410XQ8T; LUCA.
DR   GeneTree; ENSGT00550000074420; -.
DR   HOGENOM; HOG000044189; -.
DR   HOVERGEN; HBG005642; -.
DR   InParanoid; Q6P1M0; -.
DR   KO; K08745; -.
DR   OMA; WRFIRIF; -.
DR   OrthoDB; EOG091G0B76; -.
DR   PhylomeDB; Q6P1M0; -.
DR   TreeFam; TF313430; -.
DR   BRENDA; 6.2.1.3; 2681.
DR   Reactome; R-HSA-804914; Transport of fatty acids.
DR   ChiTaRS; SLC27A4; human.
DR   GeneWiki; SLC27A4; -.
DR   GenomeRNAi; 10999; -.
DR   PRO; PR:Q6P1M0; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000167114; -.
DR   CleanEx; HS_SLC27A4; -.
DR   ExpressionAtlas; Q6P1M0; baseline and differential.
DR   Genevisible; Q6P1M0; HS.
DR   GO; GO:0031526; C:brush border membrane; IEA:Ensembl.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005902; C:microvillus; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0015245; F:fatty acid transporter activity; TAS:Reactome.
DR   GO; GO:0004467; F:long-chain fatty acid-CoA ligase activity; IDA:UniProtKB.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0031957; F:very long-chain fatty acid-CoA ligase activity; IEA:Ensembl.
DR   GO; GO:0015908; P:fatty acid transport; TAS:ProtInc.
DR   GO; GO:0006629; P:lipid metabolic process; TAS:ProtInc.
DR   GO; GO:0044539; P:long-chain fatty acid import; IDA:UniProtKB.
DR   GO; GO:0001676; P:long-chain fatty acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0015909; P:long-chain fatty acid transport; TAS:Reactome.
DR   GO; GO:0001579; P:medium-chain fatty acid transport; IEA:Ensembl.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0043588; P:skin development; IEA:Ensembl.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   GO; GO:0042760; P:very long-chain fatty acid catabolic process; IEA:Ensembl.
DR   InterPro; IPR025110; AMP-bd_C.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR030304; FATP4.
DR   InterPro; IPR022272; Lipocalin_CS.
DR   PANTHER; PTHR43107:SF4; PTHR43107:SF4; 1.
DR   Pfam; PF00501; AMP-binding; 1.
DR   Pfam; PF13193; AMP-binding_C; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Fatty acid metabolism; Ichthyosis; Ligase;
KW   Lipid metabolism; Lipid transport; Membrane; Nucleotide-binding;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    643       Long-chain fatty acid transport protein
FT                                4.
FT                                /FTId=PRO_0000193209.
FT   TRANSMEM     20     42       Helical. {ECO:0000255}.
FT   TRANSMEM    139    156       Helical. {ECO:0000255}.
FT   NP_BIND     243    254       AMP. {ECO:0000255}.
FT   VAR_SEQ       1     76       MLLGASLVGVLLFSKLVLKLPWTQVGFSLLFLYLGSGGWRF
FT                                IRVFIKTIRRDIFGGLVLLKVKAKVRQCLQERRTV -> MP
FT                                LTLSTLLQPGRIWTGRRAAEPTPGHNAAWSLSGGGAAVLQA
FT                                GAETALDPGGILPVVPLLGIWRLALHPGLHQDH (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_055808.
FT   VAR_SEQ      77    482       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_055809.
FT   VARIANT      92     92       A -> T (in IPS; dbSNP:rs137853132).
FT                                {ECO:0000269|PubMed:19631310}.
FT                                /FTId=VAR_063192.
FT   VARIANT     209    209       G -> S (correlates with lower body mass
FT                                index, triglyceride concentrations,
FT                                systolic blood pressure, insulin
FT                                concentrations and homeostasis model
FT                                assessment index; dbSNP:rs2240953).
FT                                {ECO:0000269|PubMed:14715877}.
FT                                /FTId=VAR_023783.
FT   VARIANT     247    247       S -> P (in IPS; dbSNP:rs137853133).
FT                                {ECO:0000269|PubMed:19631310}.
FT                                /FTId=VAR_063193.
FT   VARIANT     300    300       Q -> R (in IPS; dbSNP:rs137853134).
FT                                {ECO:0000269|PubMed:19631310}.
FT                                /FTId=VAR_063194.
FT   VARIANT     374    374       R -> C (in IPS; dbSNP:rs768495407).
FT                                {ECO:0000269|PubMed:20815031}.
FT                                /FTId=VAR_064500.
FT   VARIANT     583    583       R -> H (in IPS; dbSNP:rs137853135).
FT                                {ECO:0000269|PubMed:19631310}.
FT                                /FTId=VAR_063195.
FT   CONFLICT    194    194       L -> P (in Ref. 1; AAD11623).
FT                                {ECO:0000305}.
FT   CONFLICT    605    605       G -> A (in Ref. 1; AAD11623).
FT                                {ECO:0000305}.
SQ   SEQUENCE   643 AA;  72064 MW;  95E677DB3CEB9A14 CRC64;
     MLLGASLVGV LLFSKLVLKL PWTQVGFSLL FLYLGSGGWR FIRVFIKTIR RDIFGGLVLL
     KVKAKVRQCL QERRTVPILF ASTVRRHPDK TALIFEGTDT HWTFRQLDEY SSSVANFLQA
     RGLASGDVAA IFMENRNEFV GLWLGMAKLG VEAALINTNL RRDALLHCLT TSRARALVFG
     SEMASAICEV HASLDPSLSL FCSGSWEPGA VPPSTEHLDP LLKDAPKHLP SCPDKGFTDK
     LFYIYTSGTT GLPKAAIVVH SRYYRMAALV YYGFRMRPND IVYDCLPLYH SAGNIVGIGQ
     CLLHGMTVVI RKKFSASRFW DDCIKYNCTI VQYIGELCRY LLNQPPREAE NQHQVRMALG
     NGLRQSIWTN FSSRFHIPQV AEFYGATECN CSLGNFDSQV GACGFNSRIL SFVYPIRLVR
     VNEDTMELIR GPDGVCIPCQ PGEPGQLVGR IIQKDPLRRF DGYLNQGANN KKIAKDVFKK
     GDQAYLTGDV LVMDELGYLY FRDRTGDTFR WKGENVSTTE VEGTLSRLLD MADVAVYGVE
     VPGTEGRAGM AAVASPTGNC DLERFAQVLE KELPLYARPI FLRLLPELHK TGTYKFQKTE
     LRKEGFDPAI VKDPLFYLDA QKGRYVPLDQ EAYSRIQAGE EKL
//
